102 related articles for article (PubMed ID: 34128342)
21. Genomic and clinical characterization of stromal infiltration markers in prostate cancer.
Mahal BA; Alshalalfa M; Zhao SG; Beltran H; Chen WS; Chipidza F; Davicioni E; Karnes RJ; Ku SY; Lotan TL; Muralidhar V; Rebbeck TR; Schaeffer EM; Spratt DE; Feng FY; Nguyen PL
Cancer; 2020 Apr; 126(7):1407-1412. PubMed ID: 31905251
[TBL] [Abstract][Full Text] [Related]
22. An endoplasmic reticulum stress-related signature featuring ASNS for predicting prognosis and immune landscape in prostate cancer.
Wu Z; Wu Z; Zeng J; Liu Y; Wang Y; Li H; Xia T; Liu W; Lin Z; Xu W
Aging (Albany NY); 2024 Jan; 16(1):43-65. PubMed ID: 38206293
[TBL] [Abstract][Full Text] [Related]
23. Tumour infiltrating lymphocytes and immune-related genes as predictors of outcome in pancreatic adenocarcinoma.
D'Angelo A; Sobhani N; Roviello G; Bagby S; Bonazza D; Bottin C; Giudici F; Zanconati F; De Manzini N; Guglielmi A; Generali D
PLoS One; 2019; 14(8):e0219566. PubMed ID: 31381571
[TBL] [Abstract][Full Text] [Related]
24. Molecular classification of prostate adenocarcinoma by the integrated somatic mutation profiles and molecular network.
Yang L; Wang S; Zhou M; Chen X; Jiang W; Zuo Y; Lv Y
Sci Rep; 2017 Apr; 7(1):738. PubMed ID: 28389666
[TBL] [Abstract][Full Text] [Related]
25. [Bioinformatics-based analysis of the effect of general Transcription Factor IIH on prognosis of Prostate cancer].
Li JC; Zhu XJ; Ye JH; Tan ZH; Cai SH; Deng YL; Chen J; Tian WC; Luo DH; Zhong WD
Zhonghua Yi Xue Za Zhi; 2024 Apr; 104(16):1410-1417. PubMed ID: 38644292
[No Abstract] [Full Text] [Related]
26. Comprehensive analysis of alternative splicing across multiple transcriptomic cohorts reveals prognostic signatures in prostate cancer.
Mou Z; Spencer J; McGrath JS; Harries LW
Hum Genomics; 2023 Nov; 17(1):97. PubMed ID: 37924098
[TBL] [Abstract][Full Text] [Related]
27. Transcriptome sequencing and multi-plex imaging of prostate cancer microenvironment reveals a dominant role for monocytic cells in progression.
Mangiola S; McCoy P; Modrak M; Souza-Fonseca-Guimaraes F; Blashki D; Stuchbery R; Keam SP; Kerger M; Chow K; Nasa C; Le Page M; Lister N; Monard S; Peters J; Dundee P; Williams SG; Costello AJ; Neeson PJ; Pal B; Huntington ND; Corcoran NM; Papenfuss AT; Hovens CM
BMC Cancer; 2021 Jul; 21(1):846. PubMed ID: 34294073
[TBL] [Abstract][Full Text] [Related]
28. Antioxidative stress protein SRXN1 can be used as a radiotherapy prognostic marker for prostate cancer.
Wang X; Yu J; Wen H; Yan J; Peng K; Zhou H
BMC Urol; 2023 Sep; 23(1):148. PubMed ID: 37726767
[TBL] [Abstract][Full Text] [Related]
29. Portraying the dark side of endogenous IFN-λ for promoting cancer progression and immunoevasion in pan-cancer.
Wang ZZ; Wen XL; Wang N; Li XH; Guo Y; Zhu X; Fu SH; Xiong FF; Li J; Wang L; Gao XL; Wang HJ
J Transl Med; 2023 Sep; 21(1):615. PubMed ID: 37697300
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of Cell Cycle-Related Genes in Patients With Prostate Cancer.
Liu Z; Pan R; Li W; Li Y
Front Oncol; 2021; 11():796795. PubMed ID: 35087757
[TBL] [Abstract][Full Text] [Related]
31. Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
Hao D; He S; Harada K; Pizzi MP; Lu Y; Guan P; Chen L; Wang R; Zhang S; Sewastjanow-Silva M; Abdelhakeem A; Shanbhag N; Bhutani M; Han G; Lee JH; Zhao S; Weston B; Blum Murphy M; Waters R; Estrella JS; Roy-Chowdhuri S; Gan Q; Lee JS; Peng G; Hanash SM; Calin GA; Song X; Zhang J; Song S; Wang L; Ajani JA
Gut; 2021 Nov; 70(11):2055-2065. PubMed ID: 33334899
[TBL] [Abstract][Full Text] [Related]
32. Mutational signature and prognosis in adenocarcinoma of the bladder.
Yang G; Shahatiaili A; Bai S; Wang L; Jin D; Cao M; Su P; Liu Q; Tao K; Long Q; Shi Y; Xiao J; Tian F; Zhang L; Chen H; Su X
J Pathol; 2024 Mar; 262(3):334-346. PubMed ID: 38180342
[TBL] [Abstract][Full Text] [Related]
33. Innovative molecular subtypes of multiple signaling pathways in colon cancer and validation of FMOD as a prognostic-related marker.
Dai Z; Peng X; Cui X; Guo Y; Zhang J; Shen X; Liu CY; Liu Y
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13087-13106. PubMed ID: 37474678
[TBL] [Abstract][Full Text] [Related]
34. Dysbindin Domain-Containing 1 in Prostate Cancer: New Insights into Bioinformatic Validation of Molecular and Immunological Features.
Tram VTN; Khoa Ta HD; Anuraga G; Dung PVT; Xuan DTM; Dey S; Wang CY; Liu YN
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569304
[TBL] [Abstract][Full Text] [Related]
35. Cell diversity and immune infiltration in the parathyroid tumour microenvironment.
Zhang X; Hu Y; Cui M; Wang M; Li X; Zhang Y; Yang S; Hua S; Shen M; Liao Q
Endocr Relat Cancer; 2023 Mar; 30(3):. PubMed ID: 36602147
[TBL] [Abstract][Full Text] [Related]
36. Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma.
Qiao S; Zhang W; Su Y; Jiang Y
Front Oncol; 2022; 12():1037535. PubMed ID: 36591519
[TBL] [Abstract][Full Text] [Related]
37. Immune infiltration phenotypes of prostate adenocarcinoma and their clinical implications.
Ma Z; Cheng X; Yue T; Shangguan X; Xin Z; Zhang W; Pan J; Wang Q; Xue W
Cancer Med; 2021 Aug; 10(15):5358-5374. PubMed ID: 34128342
[TBL] [Abstract][Full Text] [Related]
38. Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.
Zhao HB; Zeng YR; Han ZD; Zhuo YJ; Liang YK; Hon CT; Wan S; Wu S; Dahl D; Zhong WD; Wu CL
Cancer Sci; 2021 Oct; 112(10):4365-4376. PubMed ID: 34252262
[TBL] [Abstract][Full Text] [Related]
39. Long non-coding RNA profile study identifies an immune-related lncRNA prognostic signature for prostate adenocarcinoma.
Liang L; Xia W; Yao L; Wu Q; Hua L; Cheng G; Wang Z; Zhao R
Int Immunopharmacol; 2021 Dec; 101(Pt A):108267. PubMed ID: 34740081
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value and potential subtypes of immune activity scores in three major urological cancers.
Shi B; Qi J
J Cell Physiol; 2021 Apr; 236(4):2620-2630. PubMed ID: 32853461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
